Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07746076

A Clinical Trial to Evaluate the Effects of Naila's Collagen Marine Plus Food Supplement on Skin Hydration, Elasticity, Fine Lines and Wrinkles, and Hair and Nail Health

This is a single-group, open-label, virtual (decentralized) clinical trial evaluating the effects of Naila's Collagen Marine Plus Food Supplement on skin hydration, elasticity, firmness, fine lines and wrinkles, and hair and nail health over 12 weeks. Forty healthy adults aged 40-60 years with self-reported mature skin showing early signs of aging will take one sachet of the supplement daily and complete questionnaires at Baseline, Week 4, Week 8, and Week 12.

Participants will also submit standardized facial and hair photographs at Baseline and Week 12 for evaluation by a board-certified dermatologist. The primary objectives are to assess changes in skin aging parameters and hair health. Secondary objectives include evaluation of nail health, hair shedding and density, participant-reported satisfaction, and product safety and tolerability.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

30 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy adults aged 40-60 years at the time of enrollment.
  • Self-reported visible signs of skin aging, including at least one of the following: fine lines, wrinkles, reduced skin firmness or elasticity, or skin dryness.
  • Self-reports hair shedding and a desire to improve hair health.
  • Willing to take one sachet of the study product daily for 12 weeks as directed.
  • Willing to avoid taking any other collagen-containing dietary supplements for the duration of the study.
  • Willing to maintain current diet, skincare routine, sleep patterns, and physical activity levels for the duration of the trial.
  • Willing and able to submit standardized facial and hair photographs at Baseline and Week 12.
  • Has access to a smartphone or digital camera capable of producing photographs.
  • Resides in the United States.
  • Willing to follow the study protocol and complete all required questionnaires.

Exclusion criteria

  • Known allergy or sensitivity to fish, marine-derived products, or any of the study product ingredients (marine collagen, hyaluronic acid, ascorbic acid, biotin).
  • Previous diagnosis of a hair loss condition such as alopecia areata, androgenetic alopecia, or telogen effluvium.
  • Currently taking any collagen-containing dietary supplements, or planning to start taking any collagen supplements in the next 12 weeks.
  • Any current uncontrolled chronic medical condition that would prevent the participant from safely completing the study protocol.
  • History of a diagnosed dermatological condition that significantly affects facial skin appearance (e.g., severe eczema, psoriasis, rosacea, or active acne) and could confound assessment of skin aging outcomes.
  • Use of prescription retinoids, injectable dermal fillers, botulinum toxin, chemical peels, laser skin treatments, or other professional aesthetic procedures on the face within 3 months prior to enrollment or planned during the study period.
  • Currently pregnant, breastfeeding, or planning to become pregnant during the study period.
  • Currently participating in another research study or planning to participate in another study during this study's duration.
  • Any condition that, in the judgment of the investigator, would make the participant unsuitable for inclusion in the study.

Treatment and study plan

Naila's Collagen Marine Plus Food Supplement

Dietary Supplement

All 40 participants receive Naila's Collagen Marine Plus Food Supplement (one sachet daily, dissolved in approximately 200 mL of water, taken once daily in the morning) for 12 weeks.

Primary outcomes

  1. Change in Self-Reported Skin Hydration

    Time frame: Baseline to Week 12

    Mean change from Baseline in self-reported skin hydration assessed via self-reported questionnaire

  2. Change in Self-Reported Skin Elasticity

    Time frame: Baseline to Week 12

    Mean change from Baseline in self-reported skin elasticity assessed via self-reported questionnaire

  3. Change in Self-Reported Skin Firmness

    Time frame: Baseline to Week 12

    Mean change from Baseline in self-reported skin firmness assessed via self-reported questionnaire

  4. Change in Self-Reported Fine Lines and Wrinkles

    Time frame: Baseline to Week 12

    Mean change from Baseline in self-reported appearance of fine lines and wrinkles assessed via self-reported questionnaire

  5. Change in Dermatologist-Graded Fine Line and Wrinkle Severity

    Time frame: Baseline to Week 12

    Mean change from Baseline in fine line and wrinkle severity assessed by dermatologist review of standardized facial photographs

  6. Change in Dermatologist-Graded Skin Firmness

    Time frame: Baseline to Week 12

    Mean change from Baseline in skin firmness assessed by dermatologist review of standardized facial photographs

  7. Change in Dermatologist-Graded Overall Skin Quality

    Time frame: Baseline to Week 12

    Mean change from Baseline in overall skin quality assessed by dermatologist review of standardized facial photographs

  8. Change in Dermatologist-Graded Hair Parameters

    Time frame: Baseline to Week 12

    Mean change from Baseline in hair health parameters assessed by dermatologist review of standardized hair photographs

Secondary outcomes

  1. Change in Self-Reported Nail Strength

    Time frame: Baseline to Week 12

    Mean change from Baseline in self-reported nail strength assessed via self-reported questionnaire

  2. Change in Self-Reported Nail Brittleness

    Time frame: Baseline to Week 12

    Mean change from Baseline in self-reported nail brittleness assessed via self-reported questionnaire

  3. Change in Self-Reported Nail Growth Rate

    Time frame: Baseline to Week 12

    Mean change from Baseline in self-reported nail growth rate assessed via self-reported questionnaire

  4. Change in Self-Reported Overall Nail Appearance

    Time frame: Baseline to Week 12

    Mean change from Baseline in self-reported overall nail appearance assessed via self-reported questionnaire

  5. Change in Self-Reported Hair Shedding

    Time frame: Baseline to Week 12

    Mean change from Baseline in self-reported hair shedding assessed via self-reported questionnaire

  6. Change in Self-Reported Hair Thickness and Density

    Time frame: Baseline to Week 12

    Mean change from Baseline in self-reported hair thickness and density assessed via self-reported questionnaire

  7. Participant-Reported Product Satisfaction and Perceived Global Improvement

    Time frame: Week 12

    Participant-reported satisfaction and perceived global improvement assessed via self-reported questionnaire at Week 12

  8. Incidence of Adverse Events

    Time frame: Baseline through Week 12

    Number and severity of adverse events reported by participants throughout the 12-week study period, assessed via study questionnaires and reviewed by the study team

Study contacts

Contact information is provided by the study sponsor or research team.

Patrick Renner

CONTACT

[email protected]

4242450284

Sponsors and collaborators

Lead sponsor

Gulf Bird

Industry

Collaborators

  • Citruslabs

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Aug 4, 2026
Registry last updated
Aug 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.